| Description : |
This protein may play a role in carotid artery smooth muscle cell proliferation and neointimal formation in response to balloon catheter injury. |
| Source : |
E.coli |
| Species : |
Rat |
| Form : |
Lyophilized from a 0.2 μm filtered concentrated solution in 1 × PBS, pH 6.9. |
| Bio-activity : |
Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using murine Balb/c 3T3 cells is less than 2.0 ng/ml, corresponding to a specific activity of > 5.0 × 10⁵ IU/mg. |
| Molecular Mass : |
Approximately 24.4 kDa, a disulfide-linked homodimeric protein containing two 109 amino acid residues polypeptide (B chain). |
| Protein length : |
109 |
| AA Sequence : |
SLGSLAAAEPAVIAECKTRTEVFQI SRNLIDRTNANFLVWPPCVEVQRCS GCCNNRNVQCRASQVQMRPVQVRKI EIVRKKPVFKKATVTLEDHLACKCE TVVTPRPVT |
| Endotoxin : |
Less than 0.1 EU/μg of rRtPDGF-BB as determined by LAL method. |
| Purity : |
>98% by SDS-PAGE and HPLC analyses. |
| Storage : |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 centigrade as supplied. 1 month, 2 to 8 centigrade under sterile conditions after reconstitution. 3 months, -20 to -70 centigrade under sterile conditions after reconstitution. |
| Reconstitution : |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 centigrade. Further dilutions should be made in appropriate buffered solutions. |
